Success Metrics

Completion Rate

0%(0/1)

Active Trials

1(33%)

Terminated

1(33%)

Phase Distribution

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Terminated(1)

Other(1)

Detailed Status

Recruiting1

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting133%

terminated133%

unknown133%

Recent Activity

1 active trials

Showing 3 of 3

terminatednot_applicable

Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPD

NCT03584295

recruiting

Extracorporeal Carbon Dioxide Removal Using PrismaLung in Reducing Ventilator Induced Lung Injury

NCT06321497

unknown

Extracorporeal Carbon Dioxide Removal in Severe Chronic Obstructive Pulmonary Disease Exacerbation

NCT03692117

Clinical Trials (3)

Showing 3 of 3 trials

NCT03584295Not Applicable